North China Pharmaceutical Co Ltd (600812) - Total Liabilities

Latest as of March 2026: CN¥14.52 Billion CNY ≈ $2.12 Billion USD

Based on the latest financial reports, North China Pharmaceutical Co Ltd (600812) has total liabilities worth CN¥14.52 Billion CNY (≈ $2.12 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

North China Pharmaceutical Co Ltd - Total Liabilities Trend (1993–2025)

This chart illustrates how North China Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See North China Pharmaceutical Co Ltd (600812) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

North China Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of North China Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Leedarson IoT Technology Inc SHG:605365	China	CN¥2.80 Billion
Excelerate Energy Inc NYSE:EE	USA	$1.88 Billion
Bellring Brands LLC NYSE:BRBR	USA	$1.52 Billion
Sify Technologies Limited NASDAQ:SIFY	USA	$63.62 Billion
Athens Water Supply and Sewerage Company S.A AT:EYDAP	Greece	€631.79 Million
West China Cement Limited F:WFG1	Germany	€21.32 Billion
Europower Enerji ve Otomasyon Teknolojileri Sanayi Ticaret A.S. IS:EUPWR	Turkey	TL4.06 Billion
Malakoff Corporation Bhd KLSE:5264	Malaysia	RM13.53 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down North China Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 600812 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.72	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.62	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how North China Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for North China Pharmaceutical Co Ltd (1993–2025)

The table below shows the annual total liabilities of North China Pharmaceutical Co Ltd from 1993 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥14.51 Billion ≈ $2.12 Billion	-1.96%
2024-12-31	CN¥14.80 Billion ≈ $2.17 Billion	+0.75%
2023-12-31	CN¥14.69 Billion ≈ $2.15 Billion	-2.04%
2022-12-31	CN¥14.99 Billion ≈ $2.19 Billion	-16.30%
2021-12-31	CN¥17.91 Billion ≈ $2.62 Billion	+6.14%
2020-12-31	CN¥16.88 Billion ≈ $2.47 Billion	+30.65%
2019-12-31	CN¥12.92 Billion ≈ $1.89 Billion	+4.13%
2018-12-31	CN¥12.40 Billion ≈ $1.82 Billion	+4.50%
2017-12-31	CN¥11.87 Billion ≈ $1.74 Billion	+6.13%
2016-12-31	CN¥11.18 Billion ≈ $1.64 Billion	+4.26%
2015-12-31	CN¥10.73 Billion ≈ $1.57 Billion	+3.97%
2014-12-31	CN¥10.32 Billion ≈ $1.51 Billion	-0.93%
2013-12-31	CN¥10.41 Billion ≈ $1.52 Billion	+11.23%
2012-12-31	CN¥9.36 Billion ≈ $1.37 Billion	-5.93%
2011-12-31	CN¥9.95 Billion ≈ $1.46 Billion	+25.37%
2010-12-31	CN¥7.94 Billion ≈ $1.16 Billion	+23.85%
2009-12-31	CN¥6.41 Billion ≈ $937.99 Million	+19.43%
2008-12-31	CN¥5.37 Billion ≈ $785.39 Million	+2.90%
2007-12-31	CN¥5.22 Billion ≈ $763.27 Million	-7.10%
2006-12-31	CN¥5.61 Billion ≈ $821.62 Million	+1.22%
2005-12-31	CN¥5.55 Billion ≈ $811.71 Million	-5.85%
2004-12-31	CN¥5.89 Billion ≈ $862.15 Million	+30.66%
2003-12-31	CN¥4.51 Billion ≈ $659.85 Million	+5.08%
2002-12-31	CN¥4.29 Billion ≈ $627.94 Million	-7.40%
2001-12-31	CN¥4.63 Billion ≈ $678.12 Million	+41.82%
2000-12-31	CN¥3.27 Billion ≈ $478.15 Million	+12.65%
1999-12-31	CN¥2.90 Billion ≈ $424.44 Million	+44.42%
1998-12-31	CN¥2.01 Billion ≈ $293.89 Million	+28.34%
1997-12-31	CN¥1.56 Billion ≈ $229.00 Million	+12.93%
1996-12-31	CN¥1.39 Billion ≈ $202.77 Million	+34.41%
1995-12-31	CN¥1.03 Billion ≈ $150.86 Million	+51.01%
1994-12-31	CN¥682.69 Million ≈ $99.90 Million	+63.55%
1993-12-31	CN¥417.41 Million ≈ $61.08 Million	--

About North China Pharmaceutical Co Ltd

SHG:600812 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.10 Billion

CN¥7.51 Billion CNY

Market Cap Rank

#8662 Global

#2152 in China

Share Price

CN¥4.38

Change (1 day)

+0.23%

52-Week Range

CN¥4.34 - CN¥7.01

All Time High

CN¥18.60